Heinz Christoph Maeusli
Independent DirectorMr. Heinz Christoph Maeusli is Independent Non-executive Director of newcleo plc. Mr. Maeusli has been Independent Director at Inventiva S.A. since May 27, 2019. He was Chief Financial Officer of Advanced Accelerator Applications (AAA) from 2003 to 2018, Mr. Maeusli has been instrumental in growing this company into a global leader in its sector. Since November 2019, Mr. Maeusli has served on the board of directors of Progenics Pharmaceuticals. As such, he has driven the listing of AAA on the Nasdaq stock exchange in November 2015 and contributed to AAA’s sale to Novartis in January 2018. Throughout his career, he has developed an expertise in the operational, organizational, financial and cultural complexities of growing and integrating international companies. Mr. Maeusli holds an MBA from Columbia University, New York, USA in 1995 and a licentiate degree in 1988 from the University of St. Gallen.
Positions
- Company NameInventiva S.A.Stock CodeIVAPositionIndependent DirectorColleagues
- AOAndrew ObenshainChief Executive Officer
- MPMark PruzanskiIndependent Chairman
- PBPierre BroquaCo-Founder
- JVJean VolatierExecutive VP Finance & Corporate Social Responsibility
- MZMartine ZimmermannExecutive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory Affairs
- JAJason A. CampagnaPresident of Research & Development and Chief Medical Officer
- JJJean-Louis JunienChairman of Scientific Advisory Board
- GAG. Andre TurenneIndependent Director
- CSCamilla SoenderbyIndependent Director
